Baxalta agrees to terms of GBP 22bn sale to Shire
Shire (LON:SHP) has agreed to the terms of a takeover of the Bannockburn, Illinois-based drugs company Baxalta (NYSE:BXLT), city sources cited in a Sunday Times report said. An inside source said once an independent lawyer has formally signed off the deal announcement, it will be made public, the item reported.
The agreed GBP 22bn (USD 32bn) sale is to be announced within the next few days at a San Francisco-based pharmaceuticals conference, according to the sources.
The terms are believed to involve an offer worth approximately USD 48 per share and include a cash component of up to 40%, or GBP 8.8bn, the report said.
The sources cited in the report said any concerns among Baxalta shareholders relating to a potential tax bill arising from the deal have been addressed to both sides’ satisfaction.
Sunday Times